Alabama at Birmingham Comprehensive Cancer Center

Birmingham, Alabama 35294

0 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Lymphoma

Studies at this site

• Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLL — Completed